The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries?

被引:11
|
作者
Mahoney, Richard [1 ]
机构
[1] Global Hlth Consultant, Sedona, AZ 86336 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
Dengue; Vaccines; Introduction; Prelicensure; VIRUS;
D O I
10.1016/j.vaccine.2013.12.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dengue results in as many as 390 million infections annually and causes significant morbidity. A number of efforts are underway to develop vaccines against dengue. The public sector is undertaking efforts to create an enabling environment for vaccine introduction. Recent work by Brooks et al. provides a framework for analyzing which efforts should be undertaken before licensure. They conclude that actions before licensure are required to eliminate the decade or more it normally takes to introduce new vaccines into developing countries. We apply their methodology to dengue and identify a number of critical areas where public sector actions before licensure can greatly accelerate vaccine uptake. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:904 / 908
页数:5
相关论文
共 50 条
  • [1] The introduction of new vaccines into developing countries
    Mahoney, RT
    Maynard, JE
    [J]. VACCINE, 1999, 17 (7-8) : 646 - 652
  • [2] Paving the way for the introduction of new vaccines into developing countries
    Chabalgoity, JA
    [J]. EXPERT REVIEW OF VACCINES, 2005, 4 (02) : 147 - 150
  • [3] Thinking downstream to accelerate the introduction of new vaccines for developing countries
    Clemens, JD
    [J]. VACCINE, 2003, 21 : S114 - S115
  • [4] Introduction of rotavirus vaccines in developing countries: remaining challenges
    Cunliffe, Nigel
    Nakagomi, Osamu
    [J]. ANNALS OF TROPICAL PAEDIATRICS, 2007, 27 (03): : 157 - 167
  • [5] The introduction of new vaccines into developing countries II. Vaccine financing
    Mahoney, RT
    Ramachandran, S
    Xu, ZY
    [J]. VACCINE, 2000, 18 (24) : 2625 - 2635
  • [6] The introduction of new vaccines into developing countries - IV: Global access strategies
    Mahoney, Richard T.
    Krattiger, Anatole
    Clemens, John D.
    Curtiss, Roy, III
    [J]. VACCINE, 2007, 25 (20) : 4003 - 4011
  • [7] The introduction of new vaccines into developing countries - III. The role of intellectual property
    Mahoney, RT
    Pablos-Mendez, A
    Ramachandran, S
    [J]. VACCINE, 2004, 22 (5-6) : 786 - 792
  • [8] Introducing new vaccines in developing countries
    Kochhar, Sonali
    Rath, Barbara
    Seeber, Lea D.
    Rundblad, Gabriella
    Khamesipour, Ali
    Ali, Mohammad
    [J]. EXPERT REVIEW OF VACCINES, 2013, 12 (12) : 1465 - 1478
  • [9] Implementing new health interventions in developing countries: why do we lose a decade or more?
    Brooks, Alan
    Smith, Thomas A.
    de Savigny, Don
    Lengeler, Christian
    [J]. BMC PUBLIC HEALTH, 2012, 12
  • [10] Implementing new health interventions in developing countries: why do we lose a decade or more?
    Alan Brooks
    Thomas A Smith
    Don de Savigny
    Christian Lengeler
    [J]. BMC Public Health, 12